Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Our goal is to enhance the lives of people living with rare diseases.
Looking for a particular Gossamer Bio employee's phone or email?
Gossamer Bio Questions
The Gossamer Bio annual revenue was $28.5 million in 2026.
Faheem Hasnain is the Founder, CEO and Chairman of Gossamer Bio.
141 people are employed at Gossamer Bio.
Gossamer Bio is based in San Diego, California.
The NAICS codes for Gossamer Bio are [541711, 541, 54171, 42421, 54, 4242, 424, 5417, 42].
The SIC codes for Gossamer Bio are [283, 28].
Top Gossamer Bio Employees
-
Faheem Hasnain
Founder, CEO and Chairman at Gossamer Bio
San Diego, CA, US54 -
Bryan Giraudo
COO and CFO at Gossamer Bio
San Francisco, CA, US25+ -
Lou Cherico
Senior Vice President, Finance at Gossamer Bio
San Diego, CA, US23 -
Omar Gaya
VP New Products Planning at Gossamer Bio
San Diego, CA, US23 -
Kelly Dawson
Senior VP, Program Team Lead, seralutinib at Gossamer Bio
San Diego, CA, US11 -
Deanna Weber
Senior Vice President Human Resources at Gossamer Bio
San Diego, CA, US25+ -
Bryan Giraudo
Chief Financial Officer at Gossamer Bio
San Francisco, CA, US25+ -
Erin Elman
Vice President, Clinical Operations at Gossamer Bio
San Diego, CA, US13
Related Companies
